130 related articles for article (PubMed ID: 38010373)
1. Improvement of C-to-U RNA editing using an artificial MS2-APOBEC system.
Li J; Fan G; Sakari M; Tsukahara T
Biotechnol J; 2024 Jan; 19(1):e2300321. PubMed ID: 38010373
[TBL] [Abstract][Full Text] [Related]
2. Stem-loop structure preference for site-specific RNA editing by APOBEC3A and APOBEC3G.
Sharma S; Baysal BE
PeerJ; 2017; 5():e4136. PubMed ID: 29230368
[TBL] [Abstract][Full Text] [Related]
3. Programmable C-to-U RNA editing using the human APOBEC3A deaminase.
Huang X; Lv J; Li Y; Mao S; Li Z; Jing Z; Sun Y; Zhang X; Shen S; Wang X; Di M; Ge J; Huang X; Zuo E; Chi T
EMBO J; 2020 Nov; 39(22):e104741. PubMed ID: 33058229
[TBL] [Abstract][Full Text] [Related]
4. The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution.
Rathore A; Carpenter MA; Demir Ö; Ikeda T; Li M; Shaban NM; Law EK; Anokhin D; Brown WL; Amaro RE; Harris RS
J Mol Biol; 2013 Nov; 425(22):4442-54. PubMed ID: 23938202
[TBL] [Abstract][Full Text] [Related]
5. The double-domain cytidine deaminase APOBEC3G is a cellular site-specific RNA editing enzyme.
Sharma S; Patnaik SK; Taggart RT; Baysal BE
Sci Rep; 2016 Dec; 6():39100. PubMed ID: 27974822
[TBL] [Abstract][Full Text] [Related]
6. Creating RNA Specific C-to-U Editase from APOBEC3A by Separation of Its Activities on DNA and RNA Substrates.
Tang G; Xie B; Hong X; Qin H; Wang J; Huang H; Hao P; Li X
ACS Synth Biol; 2021 May; 10(5):1106-1115. PubMed ID: 33938211
[TBL] [Abstract][Full Text] [Related]
7. The implications of APOBEC3-mediated C-to-U RNA editing for human disease.
Van Norden M; Falls Z; Mandloi S; Segal BH; Baysal BE; Samudrala R; Elkin PL
Commun Biol; 2024 May; 7(1):529. PubMed ID: 38704509
[TBL] [Abstract][Full Text] [Related]
8. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
Love RP; Xu H; Chelico L
J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation.
Santa-Marta M; da Silva FA; Fonseca AM; Goncalves J
J Biol Chem; 2005 Mar; 280(10):8765-75. PubMed ID: 15611076
[TBL] [Abstract][Full Text] [Related]
10. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
[TBL] [Abstract][Full Text] [Related]
11. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK
J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704
[TBL] [Abstract][Full Text] [Related]
12. Examination of Factors Affecting Site-Directed RNA Editing by the MS2-ADAR1 Deaminase System.
Azad MTA; Qulsum U; Tsukahara T
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628635
[TBL] [Abstract][Full Text] [Related]
13. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.
Anant S; Davidson NO
Mol Cell Biol; 2000 Mar; 20(6):1982-92. PubMed ID: 10688645
[TBL] [Abstract][Full Text] [Related]
14. Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes.
Sharma S; Patnaik SK; Kemer Z; Baysal BE
RNA Biol; 2017 May; 14(5):603-610. PubMed ID: 27149507
[TBL] [Abstract][Full Text] [Related]
15. Double MS2 guided restoration of genetic code in amber (TAG), opal (TGA) and ochre (TAA) stop codon.
Bhakta S; Tsukahara T
Enzyme Microb Technol; 2021 Sep; 149():109851. PubMed ID: 34311888
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
Nair S; Zlotnick A
J Virol; 2018 May; 92(10):. PubMed ID: 29491156
[TBL] [Abstract][Full Text] [Related]
17. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
MacGinnitie AJ; Anant S; Davidson NO
J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
[TBL] [Abstract][Full Text] [Related]
18. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
[TBL] [Abstract][Full Text] [Related]
19. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
[TBL] [Abstract][Full Text] [Related]
20. Unraveling the Enzyme-Substrate Properties for APOBEC3A-Mediated RNA Editing.
Kim K; Shi AB; Kelley K; Chen XS
J Mol Biol; 2023 Sep; 435(17):168198. PubMed ID: 37442413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
